Geode Capital Management, LLC Applied Genetic Technologies Corp Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.29 - $0.89 $4,436 - $13,614
15,297 Added 2.25%
694,798 $188,000
Q2 2022

Aug 12, 2022
SELL
$0.62 - $1.1 $627 - $1,113
-1,012 Reduced 0.15%
679,501 $523,000
Q1 2022

May 13, 2022
BUY
$1.07 - $2.71 $54,042 - $136,873
50,507 Added 8.02%
680,513 $728,000
Q4 2021

Feb 11, 2022
BUY
$1.87 - $2.91 $59,553 - $92,674
31,847 Added 5.32%
630,006 $1.2 Million
Q3 2021

Nov 12, 2021
BUY
$3.01 - $4.12 $413,586 - $566,104
137,404 Added 29.82%
598,159 $1.8 Million
Q2 2021

Aug 13, 2021
SELL
$3.62 - $5.23 $612,710 - $885,214
-169,257 Reduced 26.87%
460,755 $1.8 Million
Q1 2021

May 12, 2021
BUY
$3.94 - $8.19 $1.26 Million - $2.61 Million
318,875 Added 102.49%
630,012 $3.19 Million
Q4 2020

Feb 12, 2021
BUY
$3.99 - $5.7 $105,495 - $150,708
26,440 Added 9.29%
311,137 $1.27 Million
Q3 2020

Nov 13, 2020
BUY
$4.38 - $6.43 $26,091 - $38,303
5,957 Added 2.14%
284,697 $1.38 Million
Q2 2020

Aug 13, 2020
BUY
$3.0 - $6.9 $444,387 - $1.02 Million
148,129 Added 113.41%
278,740 $1.54 Million
Q1 2020

May 14, 2020
BUY
$2.36 - $9.86 $103,080 - $430,665
43,678 Added 50.24%
130,611 $428,000
Q2 2019

Aug 14, 2019
BUY
$3.6 - $4.78 $15,289 - $20,300
4,247 Added 5.14%
86,933 $329,000
Q4 2018

Feb 13, 2019
BUY
$2.28 - $7.15 $24,872 - $77,999
10,909 Added 15.2%
82,686 $205,000
Q3 2018

Nov 13, 2018
SELL
$3.85 - $7.35 $75,764 - $144,640
-19,679 Reduced 21.52%
71,777 $523,000
Q2 2018

Aug 14, 2018
SELL
$3.7 - $5.65 $24,183 - $36,928
-6,536 Reduced 6.67%
91,456 $338,000
Q1 2018

May 15, 2018
SELL
$3.65 - $5.2 $40,000 - $56,986
-10,959 Reduced 10.06%
97,992 $377,000
Q4 2017

Feb 13, 2018
SELL
$3.4 - $4.15 $20,944 - $25,564
-6,160 Reduced 5.35%
108,951 $392,000
Q3 2017

Nov 14, 2017
SELL
$3.55 - $5.25 $147,151 - $217,617
-41,451 Reduced 26.48%
115,111 $454,000
Q2 2017

Aug 14, 2017
BUY
N/A
156,562
156,562 $798,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email